Search

Colleen Dixon and Mary Glotzbach discuss key areas for improvement, including automation, eco-friendly practices, and patient-centric delivery methods

Regeneron’s Gary Herman discusses the future of genetic medicines and the role of new delivery systems.

How AI-driven process optimization could lower costs and improve success rates in drug development.

Jason Bock highlights the need for innovative manufacturing solutions and supply chain improvements in cell therapy.

Here’s how an mRNA-based approach can overcome the development challenges of designing protein therapeutics.

Contribute to our special feature celebrating the future of pharma.

How AI in pharma can be explained with a parable of three farmers…

Assessing the effect of microgravity on the physiology of aging

Experience the future of drug manufacturing with flexible containment solutions

Can AI realistically transform data management in pharma? Yes. And it’s already begun.